TITLE

In wake of 9/11, drug-patent rules change

AUTHOR(S)
Cassels, Alan
PUB. DATE
February 2002
SOURCE
CMAJ: Canadian Medical Association Journal;2/5/2002, Vol. 166 Issue 3, p366
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the World Trade Organization meeting in Doha, Qatar in November, 2001. Debate about access to patented drugs in developing countries; Agreement to allow poor countries to make or import generic versions of patented drugs; How the September 11, 2001 terrorists attacks in the United States and subsequent bioterrorism scares may have influenced the decision.
ACCESSION #
6073944

 

Related Articles

  • WTO relaxes rule on drug patents. Vass, Alex // BMJ: British Medical Journal (International Edition);11/17/2001, Vol. 323 Issue 7322, p1146 

    Reports that the World Trade Organization will relax international drug patents. Allowance for developing countries to seek a waiver on public health grounds from the organization's rules which guarantee drug patents for twenty years; Expectation that developing counties will be allowed to...

  • WTO Members Approve 17-Year Extension of Pharmaceuticals Transition Period for LDCs.  // Bridges Weekly Trade News Digest;11/12/2015, Vol. 19 Issue 38, p18 

    The article discusses a meeting held on November 6, 2015 at the World Trade Organisation (WTO) council which approves 17-year extension of pharmaceuticals transition period for least developed countries (LCDs) till January 1, 2033.

  • The World Trade Organization's health agenda. Lipson, Debra J // BMJ: British Medical Journal (International Edition);11/17/2001, Vol. 323 Issue 7322, p1139 

    Editorial. Discusses a meeting of the World Trade Organization held in Doha, Qatar to discuss aspects of trade and intellectual property rights in relation to public health. Hope to improve access and affordability of essential medicines for diseases suffered in developing countries; Details...

  • Worldwide interest in global access to drugs. Banta, H. David; Banta, H D // JAMA: Journal of the American Medical Association;6/13/2001, Vol. 285 Issue 22, p2844 

    Discusses issues surrounding globalization and access of the world's people to pharmaceuticals. Protests at meetings of the World Trade Organization (WTO) and other groups over issues including free trade; Problem that while the economic system is becoming more global, other legal and policy...

  • WTO: SERVING THE WEALTHY, NOT THE POOR. Bello, Walden // Ecologist;Sep2000, Vol. 30 Issue 6, Special section p36 

    Argues that the World Trade Organization (WTO) and its agreements serve the interests of the United States and developed countries. How developed countries benefit from WTO agreements; Contention that developing countries can survive without WTO; Arguments being used by developed countries to...

  • Policy Options for Developing Countries for the Accessibility and Affordability of Medicines Under TRIPS. Paul, Babu; Jha, Shishir K. // ICFAI Journal of Intellectual Property Rights;Feb2009, Vol. 8 Issue 1, p10 

    The agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) came into existence along with the World Trade Organization (WTO) from January 1, 1995. Being a member of WTO, India accepted product patent protection for pharmaceuticals from January 1, 2005 onwards. The main impact...

  • Despite Doha Declaration, drug costs too high in developing world.  // Nation's Health;Dec2006/Jan2007, Vol. 36 Issue 10, p23 

    The article reports on the high costs of drugs in developing countries. After five years of the Doha Declaration, Oxfam International said wealthier nations are taking little or no action toward their promises of low-cost medications. The declaration states that developing countries must be able...

  • Rich countries did not honour Doha promises.  // TCE: The Chemical Engineer;Dec2007/Jan2008, Issue 798/799, p6 

    This article reports on the claim by charity Oxford Committee for Famine Relief (Oxfam) that the World Trade Organization's (WTO) Doha declaration, to make life-saving drugs available to poor people, is not being honored by drug firms in rich countries. In poor countries only 15% can afford...

  • At trade talks, generic-drug issue key. Itano, Nicole // Christian Science Monitor;11/9/2001, Vol. 93 Issue 243, p1 

    Reports that developing nations want a guarantee at a World Trade Organization meeting that an agreement will allow them to import generic medicines for AIDS and other epidemics. Topic of lowering trade barriers to developing nations; Issue of Trade Related Aspects of Intellectual Property...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics